Ibere Pharmaceuticals reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net income was USD 1.56 million.
1st Jan change | Capi. | |
---|---|---|
+2.67% | 987M | |
+47.91% | 961M | |
+2.39% | 668M | |
-.--% | 600M | |
-2.15% | 582M | |
+10.28% | 536M | |
-.--% | 500M | |
+6.68% | 470M | |
-.--% | 450M |